ULK1 Human Pre-designed siRNA Set A contains three designed siRNAs for ULK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ulk1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ulk1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ulk1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ulk1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

ULK2 Human Pre-designed siRNA Set A contains three designed siRNAs for ULK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ulk2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ulk2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Ulk2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ulk2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

ULK3 Human Pre-designed siRNA Set A contains three designed siRNAs for ULK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ULK4 Human Pre-designed siRNA Set A contains three designed siRNAs for ULK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UM-1 is the urinary 4-hydroxymethyl metabolite of DX-8951 (HY-13631) in human[1].

UM-2 is the urinary 3-hydroxy metabolite of DX-8951 (HY-13631) in human[1].

UM4118 is a copper ionophore that can initiate a mitochondrial-based noncanonical form of cell death known as cuproptosis. UM4118 exhibits high sensitivity in SF3B1-mutated and adverse risk acute myeloid leukemia (AML), and can be used for AML research[1].

UMOD Human Pre-designed siRNA Set A contains three designed siRNAs for UMOD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UMODL1 Human Pre-designed siRNA Set A contains three designed siRNAs for UMODL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UMPS Human Pre-designed siRNA Set A contains three designed siRNAs for UMPS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC-CA2-103 (compound 128) is a potent inhibitor of Tousled like kinase 2 (TLK2), with the IC50 of 18 nM[1].

UNC119 Human Pre-designed siRNA Set A contains three designed siRNAs for UNC119 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC119B Human Pre-designed siRNA Set A contains three designed siRNAs for UNC119B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC13A Human Pre-designed siRNA Set A contains three designed siRNAs for UNC13A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC13B Human Pre-designed siRNA Set A contains three designed siRNAs for UNC13B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC13C Human Pre-designed siRNA Set A contains three designed siRNAs for UNC13C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC13D Human Pre-designed siRNA Set A contains three designed siRNAs for UNC13D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC45A Human Pre-designed siRNA Set A contains three designed siRNAs for UNC45A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC45B Human Pre-designed siRNA Set A contains three designed siRNAs for UNC45B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC50 Human Pre-designed siRNA Set A contains three designed siRNAs for UNC50 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC5A Human Pre-designed siRNA Set A contains three designed siRNAs for UNC5A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC5B Human Pre-designed siRNA Set A contains three designed siRNAs for UNC5B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC5C Human Pre-designed siRNA Set A contains three designed siRNAs for UNC5C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC5D Human Pre-designed siRNA Set A contains three designed siRNAs for UNC5D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC80 Human Pre-designed siRNA Set A contains three designed siRNAs for UNC80 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNC8899 is a VHL-recruiting STING PROTAC degrader (DC50: 0.0.924 μM). UNC8899 can be used for viral or bacterial infection research (Blue: VHL ligand, Black: linker; Pink: STING inhibitor)[1].

UNC8900 is a VHL recruiting STING PROTAC degrader (DC50: 0.0.924 μM). UNC8900 can be used for research of viral or bacterial infection. (Blue: VHL ligand, black: linker; Pink: STING inhibitor)[1].

UNC8969 (compound 43) is a MERTK/AXL dual inhibitor with IC50s of 1.1±0.8 nM for MERTK and 5.3 ± 2.7 nM for AXL. UNC8969 also exerts a T1/2 of 7.3 h with 5 mg/kg i.v. in mice[1].

UNC9036 is a PROTAC-based STING degrader, with a DC50 of 227 nM. UNC9036-mediated STING degradation is proteasome and VHL dependent (Srtucture Note: Red, STING agonist diABZI (HY-112921A); Blue, VHL ligand VH032 (HY-120217); Black, linker)[1].

UNC93B1 Human Pre-designed siRNA Set A contains three designed siRNAs for UNC93B1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNCX Human Pre-designed siRNA Set A contains three designed siRNAs for UNCX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Undecylenoyl phenylalanine is an antagonist for α-melanocyte-stimulating hormone (MSH) and β-adrenergic receptor (β-ADR) to reduce the melanogenesis in melanocytes, reduces hyperpigmentation and thus ameliorates melasma lesions and solar lentigines[1].

UNG Human Pre-designed siRNA Set A contains three designed siRNAs for UNG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNK Human Pre-designed siRNA Set A contains three designed siRNAs for UNK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UNKL Human Pre-designed siRNA Set A contains three designed siRNAs for UNKL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Upadacitinib (Standard) is the analytical standard of Upadacitinib. Upadacitinib (ABT-494) is a potent, orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50=43 nM). Upadacitinib (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific, relevant cytokines. Upadacitinib (ABT-494) can be used for several autoimmune disorders research […]

Upadacitinib (Standard) is the analytical standard of Upadacitinib. Upadacitinib (ABT-494) is a potent, orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50=43 nM). Upadacitinib (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific, relevant cytokines. Upadacitinib (ABT-494) can be used for several autoimmune disorders research […]

Upadacitinib (Standard) is the analytical standard of Upadacitinib. Upadacitinib (ABT-494) is a potent, orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50=43 nM). Upadacitinib (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific, relevant cytokines. Upadacitinib (ABT-494) can be used for several autoimmune disorders research […]

Upadacitinib (Standard) is the analytical standard of Upadacitinib. Upadacitinib (ABT-494) is a potent, orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50=43 nM). Upadacitinib (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific, relevant cytokines. Upadacitinib (ABT-494) can be used for several autoimmune disorders research […]

Upadacitinib (Standard) is the analytical standard of Upadacitinib. Upadacitinib (ABT-494) is a potent, orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50=43 nM). Upadacitinib (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific, relevant cytokines. Upadacitinib (ABT-494) can be used for several autoimmune disorders research […]

UPB1 Human Pre-designed siRNA Set A contains three designed siRNAs for UPB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UPF1 Human Pre-designed siRNA Set A contains three designed siRNAs for UPF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UPF2 Human Pre-designed siRNA Set A contains three designed siRNAs for UPF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.